Verleden G M, Sels F, Van Raemdonck D, Verbeken E K, Lerut T, Demedts M
Dept of Pulmonary Medicine, University Hospital Gasthuisberg, Leuven, Belgium.
Eur Respir J. 1998 Apr;11(4):971-4. doi: 10.1183/09031936.98.11040971.
Idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis) is a disorder with a very poor prognosis for patients who do not respond to therapy with corticosteroids alone or in combination with immunosuppressive drugs, e.g. cyclophosphamide or azathioprine. For patients with end-stage disease, lung transplantation remains the only possibility for long-term survival. We describe a patient who received a left single lung transplant for end-stage desquamative interstitial pneumonitis. One year later, the patient again began complaining of exertional dyspnoea and a gradual decline in the transfer factor of the lung for carbon monoxide (TL,CO) was apparent. A recurrence of the primary disease in the transplanted lung was suspected on transbronchial biopsies. During treatment with high doses of steroids, a Pneumocystis carinii pneumonia developed, which was treated with co-trimoxazole. The patient completely recovered and, after a period of over 2 yrs, remained in an excellent condition, after which time he was lost from follow-up.
特发性肺纤维化(隐源性纤维性肺泡炎)对于那些单独使用皮质类固醇激素治疗或联合免疫抑制药物(如环磷酰胺或硫唑嘌呤)治疗无效的患者来说,预后非常差。对于终末期疾病患者,肺移植仍然是长期生存的唯一可能性。我们描述了一名因终末期脱屑性间质性肺炎接受左单肺移植的患者。一年后,患者再次开始抱怨劳力性呼吸困难,并且肺一氧化碳弥散量(TL,CO)逐渐下降。经支气管活检怀疑移植肺原发性疾病复发。在大剂量类固醇治疗期间,发生了卡氏肺孢子虫肺炎,用复方新诺明进行了治疗。患者完全康复,经过2年多的时间,一直状况良好,此后失去了随访。